Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido (lidocaine topical system) 1.8% is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of neuropathic pain associated with post-herpetic neuralgia. We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. Our product candidates include SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA TM), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, SP-103 (lidocaine topical system) 5.
Quote | Scilex Holding Company (NASDAQ:SCLX)
Last: | $4.43 |
---|---|
Change Percent: | -0.99% |
Open: | $4.1 |
Close: | $4.43 |
High: | $4.5899 |
Low: | $4 |
Volume: | 162,703 |
Last Trade Date Time: | 04/24/2025 03:39:41 pm |
News | Scilex Holding Company (NASDAQ:SCLX)
2025-04-15 09:01:08 ET Scilex Holding Company (SCLX) announced stock split at a ratio of 1-for-35 on 2025-04-15 ... Full story available on KlickAnalytics.com
2025-04-11 09:03:57 ET More on Scilex Seeking Alpha’s Quant Rating on Scilex Holding Company Historical earnings data for Scilex Holding Company Financial information for Scilex Holding Company Read the full article on S...
Message Board Posts | Scilex Holding Company (NASDAQ:SCLX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Scilex Holding Company Company Name:
SCLX Stock Symbol:
NASDAQ Market:
-0.99% G/L:
$4.43 Last:
162,703 Volume:
$4.10 Open:
$4.43 Close:
2025-04-15 09:01:08 ET Scilex Holding Company (SCLX) announced stock split at a ratio of 1-for-35 on 2025-04-15 ... Full story available on KlickAnalytics.com
Spire Global Inc. Class A (SPIR) is expected to report $-0.97 for Q4 2024 CaliberCos Inc. (CWD) is expected to report $-0.04 for Q4 2024 Progress Software Corporation (PRGS) is expected to report $0.79 for Q1 2025 Nuvve Holding Corp. (NVVE) is expected to report for quarter end 2024-1...
Vivos Inc (RDGL) is expected to report for quarter end 2024-12-31 Nickel Creek Platinum Corp (NCPCF) is expected to report for quarter end 2024-12-31 ViewBix Inc (VBIXD) is expected to report for quarter end 2024-12-31 Forte Biosciences Inc. (FBRX) is expected to report $-4.55 for Q4 ...